Fitch: Limited Scale and Synergies Continue to Drive De-Coupling Trend in Pharma-Chemicals Industry - Press Release - 2009/09/28 - Fitch Research

Report title: Fitch: Limited Scale and Synergies Continue to Drive De-Coupling Trend in Pharma-Chemicals Industry

from Fitch Research
785 word report published Sep 28, 2009

Price $85.00 available for immediate download

Report Overview

Search Inside

About Fitch Research

Fitch: Limited Scale and Synergies Continue to Drive De-Coupling Trend in Pharma-Chemicals Industry 28 Sep 2009 5:58 AM (EDT) Fitch Ratings-London-28 September 2009: Fitch Ratings says that most companies active in the pharmaceutical...

Report Type:

Press Release

Company(ies):

Abbott Laboratories, Akzo Nobel N.V., AstraZeneca plc, BASF SE, Bayer AG, L'Oreal SA, Merck & Company, Inc., Novartis AG, Sanofi-Aventis S.A., Solvay SA

Ticker(s):

ABT , AKZA , AZN , BAS , BAYN , MRK , NOVN , OR , SAN , SOLB

Issuer:

Solvay SA

Free Sample:

Click Here to Download

Format:

HTML

Enter the keyword(s) which you would like to search for within this document and click "Search"

Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

Also from Fitch Research

Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable $85.00
Bayer AG $165.00
Fitch: European Pharma Faces Declining Profitability on Diversification Pressures $85.00
Novartis AG $165.00
AstraZeneca PLC $425.00
Fitch Affirms AstraZeneca at 'AA-'; Outlook Stable $85.00
Solvay SA $165.00
Akzo Nobel N.V. $165.00

Price: $85.00

Free Sample

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.